These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28403531

  • 1. Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A prospective randomized controlled trial.
    Yassen AM, Elsarraf WR, Elmorshedi MA, Abdel Wahab M, Salah T, Sultan AM, Elghawalby AN, Elshobari MM, Elsadany M, Zalata K, Shiha U.
    Transpl Int; 2017 Jul; 30(7):725-733. PubMed ID: 28403531
    [Abstract] [Full Text] [Related]

  • 2. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation.
    Ko JS, Kim GS, Gwak MS, Yang M, Kim HK, Shin BS, Kim JK, Lee SK.
    Transplant Proc; 2008 Dec; 40(10):3308-10. PubMed ID: 19100378
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of living donor liver preservation with HTK solution.
    Ringe B, Braun F, Moritz M, Zeldin G, Soriano H, Meyers W.
    Transplant Proc; 2005 Dec; 37(1):316-9. PubMed ID: 15808629
    [Abstract] [Full Text] [Related]

  • 4. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation.
    Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Cullen J, Lansing K, Bozorgzadeh A.
    Exp Clin Transplant; 2006 Jun; 4(1):451-7. PubMed ID: 16827642
    [Abstract] [Full Text] [Related]

  • 5. Comparable outcome of liver transplantation with histidine-tryptophan-ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial.
    Kaltenborn A, Gwiasda J, Amelung V, Krauth C, Lehner F, Braun F, Klempnauer J, Reichert B, Schrem H.
    BMC Gastroenterol; 2014 Sep 28; 14():169. PubMed ID: 25263587
    [Abstract] [Full Text] [Related]

  • 6. An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation.
    Compagnon P, Levesque E, Hentati H, Disabato M, Calderaro J, Feray C, Corlu A, Cohen JL, Ben Mosbah I, Azoulay D.
    Transplantation; 2017 Jul 28; 101(7):e205-e213. PubMed ID: 28403128
    [Abstract] [Full Text] [Related]

  • 7. Impact of venous systemic oxygen persufflation supplemented with nitric oxide gas on cold-stored, warm ischemia-damaged experimental liver grafts.
    Srinivasan PK, Yagi S, Doorschodt B, Nagai K, Afify M, Uemoto S, Tolba R.
    Liver Transpl; 2012 Feb 28; 18(2):219-25. PubMed ID: 21987402
    [Abstract] [Full Text] [Related]

  • 8. [Outcomes using two preservation solutions (UW/HTK) in liver transplantation from brain death donors].
    Martínez J, Bächler JP, Moisan F, Torres J, Duarte I, Pérez RM, Benítez C, Arrese M, Domínguez P, Guerra JF, Jarufe N.
    Rev Med Chil; 2014 Oct 28; 142(10):1229-37. PubMed ID: 25601106
    [Abstract] [Full Text] [Related]

  • 9. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study.
    Testa G, Malagó M, Nadalin S, Treptow B, Paul A, Frilling A, Broelsch CE.
    Liver Transpl; 2003 Aug 28; 9(8):822-6. PubMed ID: 12884194
    [Abstract] [Full Text] [Related]

  • 10. Antegrade Hepatic Artery and Portal Vein Perfusion Versus Portal Vein Perfusion Alone in Living Donor Liver Transplantation: A Randomized Trial.
    Shaji Mathew J, Kumar KYS, Nair K, Thankamony Amma BSP, Krishnakumar L, Balakrishnan D, Gopalakrishnan U, Menon RN, Sunny A, Dhar P, Othiyil Vayoth S, Surendran S.
    Liver Transpl; 2019 Sep 28; 25(9):1353-1362. PubMed ID: 30908879
    [Abstract] [Full Text] [Related]

  • 11. Effect of university of wisconsin and histidine-tryptophan-ketoglutarate preservation solutions on blood potassium levels of patients undergoing living-donor liver transplantation.
    Juang SE, Huang HW, Kao CW, Chen CL, Lu HF, Cheng KW, Huang CJ, Wu SC, Jawan B, Wang CH.
    Transplant Proc; 2012 Mar 28; 44(2):366-8. PubMed ID: 22410018
    [Abstract] [Full Text] [Related]

  • 12. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J, Van Gelder F, Coosemans W, Aerts R, Gunson B, Koshiba T, Fourneau I, Mirza D, Van Steenbergen W, Fevery J, Nevens F, McMaster P.
    Liver Transpl; 2001 Jun 28; 7(6):540-5. PubMed ID: 11443584
    [Abstract] [Full Text] [Related]

  • 13. Effects of N-Acetylcysteine Addition to University of Wisconsin Solution on the Rate of Ischemia-Reperfusion Injury in Adult Orthotopic Liver Transplant.
    Aliakbarian M, Nikeghbalian S, Ghaffaripour S, Bahreini A, Shafiee M, Rashidi M, Rajabnejad Y.
    Exp Clin Transplant; 2017 Aug 28; 15(4):432-436. PubMed ID: 26114393
    [Abstract] [Full Text] [Related]

  • 14. Preliminary results of a clinical randomized study comparing Celsior and HTK solutions in liver preservation for transplantation.
    Nardo B, Bertelli R, Montalti R, Beltempo P, Puviani L, Pacilè V, Cavallari A.
    Transplant Proc; 2005 Aug 28; 37(1):320-2. PubMed ID: 15808630
    [Abstract] [Full Text] [Related]

  • 15. Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein.
    Chan SC, Lo CM, Ng KK, Ng IO, Yong BH, Fan ST.
    Liver Transpl; 2011 Feb 28; 17(2):115-21. PubMed ID: 21280183
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation using University of Wisconsin or Celsior preserving solutions in the portal vein and Euro-Collins in the aorta.
    Duca WJ, da Silva RF, Arroyo PC, Sgnolf A, Cabral CM, Ayres DC, Felício HC, da Silva RD.
    Transplant Proc; 2010 Mar 28; 42(2):429-34. PubMed ID: 20304157
    [Abstract] [Full Text] [Related]

  • 17. Iloprost donor treatment reduces ischemia-reperfusion injury in an isolated extracorporeal pig liver perfusion model.
    Schoening WN, Feige I, Schubert T, Olschewski P, Buescher N, Helbig M, Schmitz V, Neuhaus P, Pratschke J, Puhl G.
    Exp Clin Transplant; 2015 Feb 28; 13(1):51-61. PubMed ID: 25654413
    [Abstract] [Full Text] [Related]

  • 18. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation.
    Wu TJ, Dahiya D, Lee CS, Lee CF, Chou HS, Chan KM, Lee WC.
    Liver Transpl; 2011 Sep 28; 17(9):1035-45. PubMed ID: 21542130
    [Abstract] [Full Text] [Related]

  • 19. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.
    Liver Transpl; 2009 Dec 28; 15(12):1776-82. PubMed ID: 19938139
    [Abstract] [Full Text] [Related]

  • 20. Improved preservation and microcirculation with POLYSOL after partial liver transplantation in rats.
    Yagi S, Doorschodt BM, Afify M, Klinge U, Kobayashi E, Uemoto S, Tolba RH.
    J Surg Res; 2011 May 15; 167(2):e375-83. PubMed ID: 21392801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.